Cargando…

Dendrite pathology and neurodegeneration: focus on mTOR

Detalles Bibliográficos
Autor principal:	Di Polo, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424745/ https://www.ncbi.nlm.nih.gov/pubmed/26170813 http://dx.doi.org/10.4103/1673-5374.155421

Ejemplares similares

The local mammalian target of rapamycin (mTOR) modulation: a promising strategy to counteract neurodegeneration
por: Dolcetta, Diego, et al.
Publicado: (2019)

Roles of mTOR in Diabetic Kidney Disease
por: Yasuda-Yamahara, Mako, et al.
Publicado: (2021)

mTOR, glycotoxins and the parallel universe
por: Green, Alan S.
Publicado: (2018)

mTOR coordinates protein synthesis, mitochondrial activity and proliferation
por: Morita, Masahiro, et al.
Publicado: (2015)

How does mTOR sense glucose starvation? AMPK is the usual suspect
por: Leprivier, Gabriel, et al.
Publicado: (2020)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injury
por: Morquette, B, et al.
Publicado: (2015)

mTOR inhibitors effects on regulatory T cells and on dendritic cells
por: Stallone, Giovanni, et al.
Publicado: (2016)

Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1
por: Maiese, Kenneth
Publicado: (2020)

Targeting mTOR for the treatment of AML. New agents and new directions
por: Altman, Jessica K., et al.
Publicado: (2011)

M(o)TOR of aging: MTOR as a universal molecular hypothalamus
por: Blagosklonny, Mikhail V.
Publicado: (2013)

Expression of mTOR in normal and pathological conditions
por: Marques-Ramos, A, et al.
Publicado: (2023)

mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in Neurodegeneration
por: Norwitz, Nicholas G., et al.
Publicado: (2020)

Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
por: Hayashi, Takahiro, et al.
Publicado: (2023)

Elucidating the pathological mechanisms of neurodegeneration in the lethal serpinopathy FENIB
por: Miranda, Elena, et al.
Publicado: (2022)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Activation of mTOR Ameliorates Fragile X Premutation rCGG Repeat-Mediated Neurodegeneration
por: Lin, Yunting, et al.
Publicado: (2013)

The Phosphatidylinositol 3-Kinase/mTor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration
por: Heras-Sandoval, David, et al.
Publicado: (2011)

Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration
por: Zheng, Xinde, et al.
Publicado: (2016)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

mTOR controls lysosome tubulation and antigen presentation in macrophages and dendritic cells
por: Saric, Amra, et al.
Publicado: (2016)

Regulation of RLR-Mediated Antiviral Responses of Human Dendritic Cells by mTOR
por: Fekete, Tünde, et al.
Publicado: (2020)

Neuroligin 3 Regulates Dendritic Outgrowth by Modulating Akt/mTOR Signaling
por: Xu, Jing, et al.
Publicado: (2019)

The Interfaces Between Signal Transduction Pathways: IGF-1/mTor, p53 and the Parkinson Disease Pathway
por: Levine, Arnold J., et al.
Publicado: (2012)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain—Implications for Neurodegeneration
por: Lanzillotta, Chiara, et al.
Publicado: (2020)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

mTOR and Tumor Cachexia
por: Duval, Adrian P., et al.
Publicado: (2018)

Double agent mTOR
por: Danzer, Steve C.
Publicado: (2019)

mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019)

Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016)

Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies
por: Liu, Joan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n3veghql5bst74ad32rg49a48c